AAP
33
4
PCG
83
3
UNH
57
4
AON
56
4
EQIX
64
-5
C
60
2
KHC
56
6
DIS
68
3
CMS
67
2
NWSA
58
4
PCAR
48
2
AES
58
3
WBA
27
8
NWL
57
3
SHW
71
-2
WDC
59
-2
KLAC
63
-5
YUM
56
4
IVZ
63
-3
MA
64
4
AAP
33
4
PCG
83
3
UNH
57
4
AON
56
4
EQIX
64
-5
C
60
2
KHC
56
6
DIS
68
3
CMS
67
2
NWSA
58
4
PCAR
48
2
AES
58
3
WBA
27
8
NWL
57
3
SHW
71
-2
WDC
59
-2
KLAC
63
-5
YUM
56
4
IVZ
63
-3
MA
64
4
Financhill
Back

Marinus Pharmaceuticals Vs. Cellectar Biosciences Industry Stock Comparison

Sell
41

MRNS
Marinus Pharmaceuticals

Last Price:
1.84
Seasonality Move:
2.77%
Sell
44

CLRB
Cellectar Biosciences

Last Price:
2.05
Seasonality Move:
-16.85%
Sell
41
Marinus Pharmaceuticals (MRNS) is a Sell

Is Marinus Pharmaceuticals a Buy, Sell or Hold?

  • The current Marinus Pharmaceuticals [MRNS] share price is $1.84. The Score for MRNS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.04. The Score for CLRB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MRNS Stock Price Chart

What is Marinus Pharmaceuticals's stock price today?

  • The Marinus Pharmaceuticals share price today is $1.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRNS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.

MRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 67.93 Buy
Chaikin Money Flow: 406339 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.37 - 1.67) Buy
Bollinger Bands (100): (1.25 - 1.53) Buy

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 46.45 Sell
Chaikin Money Flow: 166076 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.02 - 2.18) Sell
Bollinger Bands (100): (2.04 - 3) Sell

MRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.7 Buy
20-day SMA: 1.54 Buy
50-day SMA: 1.41 Buy
200-day SMA: 4.82 Sell
8-day EMA: 1.71 Buy
20-day EMA: 1.59 Buy
50-day EMA: 1.54 Buy
200-day EMA: 3.65 Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.02 Buy
20-day SMA: 2.08 Sell
50-day SMA: 2.12 Sell
200-day SMA: 2.97 Sell
8-day EMA: 2.01 Buy
20-day EMA: 2.06 Sell
50-day EMA: 2.19 Sell
200-day EMA: 2.63 Sell

Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.22 per share, an increase this year of $0.65 per share, and an increase next year of $0.93 per share.

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Marinus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):